View drug registration information details.
| Items | Registration information |
|---|
| ID | 2071 |
|---|
| No | 2071 |
|---|
| Brand Name | LAMIVIR |
|---|
| Ingredients | LAMIVUDINE USP 100 MG |
|---|
| Dosage Form | TABLET |
|---|
| Primary Packaging | ALU-PVC BLISTER |
|---|
| Storage | |
|---|
| Shelf Life | 3 YEARS |
|---|
| Pack Size | BOX OF 2 X 10'S |
|---|
| Dispensing Category | |
|---|
| ATC Classification | |
|---|
| Pharmaceutical Class | |
|---|
| Indications | TREATMENT OF CHRONIC HEPATITIS B ASSOCIATED WITH EVIDENCE OF HEPATITIS B VIRAL REPLICATION AND ACTIVE LIVER INFLAMMATION |
|---|
| Contraindications | |
|---|
| Side Effects | |
|---|
| Unit Price | |
|---|
| EDL |
NULL |
|---|
| Description | ROUND SHAPED LIGHT PINK COLORED FILM COATED TABLET HAVING A BISECT LINE ON ONE SIDE |
|---|
| Note | |
|---|
| License Owner | PALAMY PHARMA CO., LTD |
|---|
| Manufacturer | INCEPTA PHARMACEUTICALS LIMITED |
|---|
| Country | BANGLADESH |
|---|
| Import Registration No | |
|---|
| Import Registration Date | |
|---|
| Activity | CERTIFICATE RELEASED |
|---|
| Applied Date | |
|---|
| FDD Registration No | 05 I 3322/09 |
|---|
| FDD Registration Date | 23-NOV-2023 |
|---|
| Expiry Date | 22-Nov-2026 |
|---|
Back to drug list
|
